home / stock / stro / stro articles

STRO Articles, Sutro Biopharma Inc. - From 11/11/23

Stock Information
Company Name: Sutro Biopharma Inc.
Stock Symbol: STRO
Market: NASDAQ
Website: sutrobio.com
Menu
STRO STRO Quote STRO Short STRO News STRO Articles STRO Message Board
Get STRO Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sutro Biopharma, Inc. (NASDAQ: STRO) and Encourages Investors to Contact the Firm | Benzinga

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Sutro Biopharma, Inc. (NASDAQ:STRO) ("Sutro"...
INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Sutro Biopharma, Inc.; Urges Sutro Stockholders to Contact Abbott Cooper Regarding Their Legal Rights | Benzinga

STAMFORD, Conn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Sutro Biopharma, Inc. (NASDAQ:STRO) ("Sutro" or the "Comp...

Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference | Benzinga

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage onco...

Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside | Benzinga

Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.  The analysts ...
Sutro Biopharma Chief Business Officer Sold $72K In Company Stock | Benzinga

Brunilda Shtylla, Chief Business Officer at Sutro Biopharma (NASDAQ:STRO), reported a large insider sell on August 29, according to a new SEC filin...

Sutro Biopharma to Participate in Upcoming Investor Conferences | Benzinga

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage onco...

Chief Business Officer of Sutro Biopharma Sold $53K In Stock | Benzinga

Brunilda Shtylla, Chief Business Officer at Sutro Biopharma (NASDAQ:STRO), reported a large insider sell on August 28, according to a new SEC filin...
Previous 10 Next 10